Synapse Open Synapse
Science

This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

Nature News · · 4 min read

Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.

Same story elsewhere

Latest from Nature News